October 2025 in “Nepal Journal of Dermatology Venereology & Leprology” In this case study, a 55-year-old male farmer from Nepal with a kerion barbae in the beard region showed complete resolution after initiating oral itraconazole, highlighting the potential for misdiagnosis when bacterial superinfection complicates dermatophyte infections.
October 2025 in “Indian Journal of Dermatology Venereology and Leprology” This source suggests that the metaverse could play a crucial role in dermatology by offering new ways to manage chronic skin conditions and improve patient support and education, especially for those hesitant to seek in-person consultations.
July 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” In this study involving 20 participants with alopecia areata, microneedling was reported to clinically improve hair density and growth in affected areas, with results starting around one month and concluding three months after the final treatment session.
July 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review reports that the human amniotic membrane has promising regenerative, anti-inflammatory, and antimicrobial properties, suggesting its potential for innovative clinical applications in dermatology, such as wound healing and psoriasis treatment, as well as aesthetic uses like skin rejuvenation and hair regeneration.
July 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” In this review, researchers examined the concentration of cortisol in scalp hair of individuals with alopecia areata to explore its relationship with disease variables, as cortisol in hair can indicate chronic stress, which may impact alopecia areata pathogenesis.
July 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review explores the potential of microneedling as a drug delivery system for treating melasma, focusing on its mechanisms, safety, efficacy, and clinical advantages over conventional therapies like hydroquinone and lasers.
July 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review assessed the role of scalp hair Survivin protein in individuals with premature graying, exploring its potential involvement in graying-related processes and highlighting its overexpression in autoimmune diseases that may influence the survival of specific immune cell clones.
March 2025 in “Indian Journal of Dermatology Venereology and Leprology” In this study, tofacitinib showed significant efficacy in treating alopecia totalis and universalis over a 6-month period, with notable hair regrowth outcomes, while younger age of onset and shorter treatment duration were linked to less effectiveness.
March 2025 in “Nepal Journal of Dermatology Venereology & Leprology” This study observed that Nepalese dermatologists commonly manage telogen effluvium with counseling and supplements, despite the lack of a consensus management guideline.
January 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” In this hospital-based study, researchers found that serum ferritin levels were significantly lower in individuals with acne compared to healthy controls, suggesting a possible link between iron deficiency and acne pathogenesis.
January 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review article highlights that obesity is a significant risk factor for several inflammatory skin conditions, such as psoriasis and atopic eczema, contributing to increased overall morbidity among those affected.
January 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study found that oral tofacitinib significantly reduced alopecia severity and improved quality of life over 12 months for children with moderate to severe alopecia areata, though the authors recommend more research due to the small sample size and absence of a control group.
January 2025 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review discusses the various off-label treatments for alopecia areata, highlighting that these therapies may promote hair growth but are not curative.
December 2024 in “Indian Journal of Dermatology Venereology and Leprology” Atypical male hair loss may not respond to usual treatments.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology”
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
August 2024 in “Indian Journal of Dermatology Venereology and Leprology” The book provides comprehensive treatment strategies for female hair loss.
August 2024 in “Indian Journal of Dermatology Venereology and Leprology”
July 2024 in “Indian Journal of Dermatology Venereology and Leprology” This study found that specific PITX2 gene variants are significantly associated with higher risk of androgenetic alopecia in males, highlighting important genetic and environmental interactions influencing its development.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This pilot clinical trial observed that combining subcision using a blunt cannula with platelet-rich plasma injections and microneedling for post-acne rolling scars was associated with a significant positive correlation between physician satisfaction and age of acne onset.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This pilot study evaluated a hair growth serum on 51 individuals aged 21 to 45, observing that it effectively reduced hair fall, promoted hair growth, and increased hair thickness and density without side effects, with high user satisfaction in Mumbai, India.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This review highlights the increasing use of trichoscopy, a noninvasive and well-tolerated diagnostic tool, to aid in the accurate diagnosis and management of various pediatric hair and scalp conditions, such as alopecia and other abnormalities.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study observed that techniques using autologous cellular micrografts to isolate hair follicle stem cells from scalp biopsies show promise in improving hair density and thickness for androgenetic alopecia, offering a minimally invasive and potentially more compliant alternative to existing treatments like finasteride and minoxidil.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study reported that surgical treatments for vitiligo, including tissue and cellular grafting methods, are safe and effective in selected patients, although specific advantages and disadvantages vary by technique.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study discusses that many patients experience temporary hair loss after bariatric surgery, potentially due to rapid weight loss, surgery stress, and nutritional deficiencies, including shortages of iron, zinc, and other nutrients crucial for hair health.
July 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study suggests that topical minoxidil could promote hair regrowth in individuals with alopecia areata by exerting a localized immunosuppressive effect, and that combining minoxidil with other treatments may enhance hair growth outcomes.
January 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study reports that an intervention decreased glucose and insulin levels, indicating improved insulin resistance, which is linked to a skin condition called acne vulgaris and other disorders associated with insulin resistance.
January 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This literature review indicates that tofacitinib, both orally and topically, holds promise as a safe and effective treatment for various dermatological conditions in pediatric patients, though its use requires careful consideration of its benefits and risks.
March 2022 in “Nepal Journal of Dermatology Venereology & Leprology” In this prospective clinical trial, azathioprine with steroid minipulse therapy and methotrexate with steroid minipulse therapy both improved hair regrowth in alopecia areata patients, but methotrexate showed slightly higher efficacy.
July 2020 in “International Journal of Dermatology Venereology and Leprosy Sciences” In this study, dermatological changes were highly prevalent among postmenopausal women, with xerosis, pigmentary changes, and hair thinning being the most common findings, suggesting such changes are often overlooked in clinical practice.